Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bongard, D.H.J.G. van den"'
Autor:
Eijkelboom, A.H., Munck, L., Menke van der Houven van Oordt, C.W., Broeders, M.J., Bongard, D.H.J.G. van den, Strobbe, L.J.A., Mureau, M.A.M., Lobbes, M.B., Westenend, P.J., Koppert, L.B., Jager, A., Siemerink, E.J., Wesseling, J., Verkooijen, H.M., Vrancken Peeters, M.T.F.D., Smidt, M.L., Tjan-Heijnen, V.C., Siesling, S.
Publikováno v:
Breast Cancer Research and Treatment, 197, 1, pp. 161-175
Breast Cancer Research and Treatment, 197, 161-175
Breast Cancer Research and Treatment, 197, 161-175
Contains fulltext : 290891.pdf (Publisher’s version ) (Open Access) PURPOSE: We aimed to compare (1) treatments and time intervals between treatments of breast cancer patients diagnosed during and before the COVID-19 pandemic, and (2) the number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3eeed4886689ece13ddcd45585201308
Autor:
Middelburg, J.G., Middelburg, R.A., Zwienen, M. van, Mast, M.E., Bhawanie, A., Jobsen, J.J., Rozema, T., Maas, H., Geijsen, E.D., Leest, A.H. van der, Bongard, D.H.J.G. van den, Loon, J. van, Budiharto, T., Aarts, M.J., Terhaard, C.H.J., Struikmans, H., LPRO Dutch Natl Org Radiotherapy E
Publikováno v:
Clinical Oncology, 33(4), E203-E210. ELSEVIER SCIENCE LONDON
Clinical oncology, 33(4), E203-E210. Elsevier Science
Clinical oncology (Royal College of Radiologists (Great Britain)), 33(4), e203-e210. W.B. Saunders Ltd
Clinical Oncology, 33(4), e203-e210. W.B. Saunders
Clinical oncology, 33(4), E203-E210. Elsevier Science
Clinical oncology (Royal College of Radiologists (Great Britain)), 33(4), e203-e210. W.B. Saunders Ltd
Clinical Oncology, 33(4), e203-e210. W.B. Saunders
Aims: To investigate whether the Geriatric 8 (G8) score and the Timed Get Up and Go Test (TGUGT), together with clinical and demographic patient characteristics, are associated with survival and late toxicity after (chemo)radiation therapy, administe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e6cd4fe21b2b9dc77bce111655ea5c
https://hdl.handle.net/11370/e287f3f1-0807-409c-a016-4c3adec8bc56
https://hdl.handle.net/11370/e287f3f1-0807-409c-a016-4c3adec8bc56
Autor:
Jacobs, D.H.M., Charaghvandi, R.K., Horeweg, N., Maduro, J.H., Speijer, G., Roeloffzen, E.M.A., Mast, M., Bantema-Joppe, E., Petoukhova, A.L., Bongard, D.H.J.G. van den, Koper, P., Crijns, A.P.G., Marijnen, C.A.M., Verkooijen, H.M.
Purpose To evaluate and compare health-related quality of life (HRQL) of women with early-stage breast cancer (BC) treated with different radiotherapy (RT) regimens. Methods Data were collected from five prospective cohorts of BC patients treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::f31c2ce2720d3e3eab9590dedbd20488
https://hdl.handle.net/1887/3278811
https://hdl.handle.net/1887/3278811
Autor:
Eijkelboom, A.H., Munck, L. de, Peeters, M.J.T.F.D.V., Broeders, M.J.M., Strobbe, L.J.A., Bos, M.E.M.M., Schmidt, M.K., Paez, C.G., Smidt, M.L., Bessems, M., Verloop, J., Linn, S., Lobbes, M.B.I., Honkoop, A.H., Bongard, D.H.J.G. van den, Westenend, P.J., Wesseling, J., Oordt, C.W.M. van, Tjan-Heijnen, V.C.G., Siesling, S., NABON COVID 19 Consortium, COVID Canc-NL Consortium
Background The onset of the COVID-19 pandemic forced the Dutch national screening program to a halt and increased the burden on health care services, necessitating the introduction of specific breast cancer treatment recommendations from week 12 of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::acc19253b693ff9c00c75931a06a8f9e
https://hdl.handle.net/1887/3280184
https://hdl.handle.net/1887/3280184
Autor:
Eijkelboom, A.H., Munck, L. de, Peeters, M.J.T.F.D.V., Broeders, M.J.M., Strobbe, L.J.A., Bos, M.E.M.M., Schmidt, M.K., Paez, C.G., Smidt, M.L., Bessems, M., Verloop, J., Linn, S., Lobbes, M.B.I., Honkoop, A.H., Bongard, D.H.J.G. van den, Westenend, P.J., Wesseling, J., Oordt, C.W.M. van, Tjan-Heijnen, V.C.G., Siesling, S., NABON COVID 19 Consortium, COVID Canc-NL Consortium
Background The onset of the COVID-19 pandemic forced the Dutch national screening program to a halt and increased the burden on health care services, necessitating the introduction of specific breast cancer treatment recommendations from week 12 of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______202::acc19253b693ff9c00c75931a06a8f9e
https://hdl.handle.net/1887/3280184
https://hdl.handle.net/1887/3280184